来自MSN3 天
ImmunityBio Surges On FDA Green Light For Expanded Bladder Cancer Vaccine Access — Retail ...
Shares of ImmunityBio Inc. surged 16.4% on Wednesday, marking their best session in over a month, and extended gains in after ...
Why ImmunityBio, Inc. (IBRX) Went Up On Wednesday?
We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to ...
Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian ...
Garmin reported fiscal fourth-quarter 2024 revenue growth of 23% year-on-year to $1.82 billion, beating the analyst consensus estimate of $1.70 billion. The GPS navigation and wearable technology ...
Why ImmunityBio (IBRX) Is Surging Today
ImmunityBio (IBRX) is jumping 20% after the drug maker reported that the FDA had approved its use of an “alternative source ...
FDA authorizes ImmunityBio to provide rBCG to urologists amid shortages
ImmunityBio (IBRX) announced the U.S. Food and Drug Administration FDA has authorized an expanded access program EAP that will bring a vital ...
FDA批准ImmunityBio膀胱癌药物扩大使用范围
加利福尼亚州卡尔弗城 - 市值24.6亿美元的免疫疗法公司ImmunityBio, Inc. (NASDAQ: IBRX )获得美国食品和药物管理局（FDA）授权，批准其扩大使用计划（EAP），为美国膀胱癌治疗提供新的卡介苗（BCG）来源。这一进展是为了应对过去一年影响患者治疗的TICE® BCG短缺问题。根据 InvestingPro ...
FDA Authorizes ImmunityBio to Provide Recombinant BCG (rBCG) to Urologists to Address TICE ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...
Optimism in War on Cancer on the Rise, as Biotech Companies Roll Out More Wins
Detailed price information for Immunitybio Inc (IBRX-Q) from The Globe and Mail including charting and trades.